All filters
E-Posters
Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine - Farihah Malik
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Pharmacist-led telephone clinic is an effective strategy for treating patients with hepatitis C and removing barriers to attending appointments - Andrew Sommerville
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Frequency of IN gene region polymorphisms associated with ALLINIs effectiveness in HIV-1 subtype A6 dominating in Russia - Ilya Lapovok
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Pretreated drug-resistance in newly diagnosed HIV-1 patients in Portugal between 2014 and 2019 - Marta Pingarilho
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Application of the genetic diversity analysis for determination of HIV infection duration - Anastasia Murzakova
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Integrase genotyping is highly effective on diverse HIV-1 non-B clades circulating in Cameroon: toward a successful transition to Dolutegravir-based regimens in Africa - Ezechiel Ngoufack Jagni Semengue
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement - Robert Ehret
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
A Public Health Approach to Sustainability of Community Based HCV Treatment among HIV/HCV Co-infected KPs through programmatic cost efficiency in Ukraine - Zahedul Islam
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Sensitivity of ultra-deep sequencing for dual HIV infection detection - Darya Saleeva
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
A Multi-Allelic Molecular-Beacon-Based Real-Time RT-PCR Assay for the Detection of the Coronavirus SARS-CoV-2 from Clinical Samples - Andreas Chrysostomou
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Use of Fibroquel® (type I polymerized collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico. - Luis Del Carpio-Orantes
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
PK-virological algorithm to target risk of resistance among key populations in Togo - Valentine Ferré
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Longitudinal Evaluation of Sequencing Quality in EQA-Schemes from 2014 to 2020 - Marcel Schuetze
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Andrea Del Luca Lecture & Roundtable debate
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic - Andreas Chrysostomou, MSc
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Usefulness of Next-Generation Sequencing on PBMC Samples and HIV-1 DNA Quantification in Management of Treatment Optimization in HIV-1 Infected Virologically Suppressed Individuals - Daniele Armenia
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
APOBEC Editing in HIV DNA Proviral Vif and Pol Long-Reads Issued from Virologically-Suppressed Patients Included in the ANRS LAMIDOL Trial - Charlotte Charpentier, PharmD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Dynamics of Total and Intact HIV-1 DNA in in Virologically Suppressed Patients Switching to DTG+3TC or ATV/r+3TC Dual Therapy - Filippo Dragoni, MD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Exploration of the Possible Mechanisms Leading to Greater Mortality in People with Limited Drug Options (LDO) - Alessandro Cozzi-Lepri, MD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Determinants of HIV-1 Late Presentation in Patients Followed in Europe- Mafalda Miranda, MD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Exploratory Analysis of Baseline Phenotypic and Genotypic Parameters in Relation to Antiviral Activity for Fostemsavir (FTR) in Heavily Treatment-Experienced (HTE) Patients in the Phase 3 BRIGHTE Study - Margaret Gartland
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
HIV-1Reverse Transcriptase Natural Polymorphism V106I Does Not Alter the Susceptibility and the Genetic Barrier to Resistance to Doravirine in Vitro - Federica Giammarino, MD
Presented at:
European Meeting on HIV & Hepatitis 2021